"Given their intent to separate and form some distinction, shouldn't pose any problem being involved with both, I take it?" I would like to know the answer to this question also.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025